Quick Takeaways
- Samsara BioCapital, L.P. filed SCHEDULE 13D/A for Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS).
- Disclosed ownership: 2.6%.
- Date of event: 18 Nov 2024.
Samsara BioCapital, L.P. - 18 Nov 2024 SCHEDULE 13D/A Report for Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS)
- Filing Manager
- Samsara BioCapital, L.P.
- Reporting Manager
- Samsara BioCapital, L.P.
- Symbol
- SYRS
- Shares outstanding
- 27,196,692 shares
- Disclosed Ownership
- 707,114 shares
- Ownership
- 2.6%
- Form type
- SCHEDULE 13D/A
- Filing time
- 27 Mar 2025, 18:17:04 UTC
- Date of event
- 18 Nov 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Samsara BioCapital, L.P. disclosed 2.6% ownership in Syros Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (SYRS) on 18 Nov 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Mar 2025, 18:17.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. | 2.6% | 707,114 | 0 | 707,114 | /s/ Srinivas Akkaraju | By Samsara BioCapital GP, LLC, its General Partner, By Srinivas Akkaraju, Managing Member | 0001699737 |
| Samsara BioCapital GP, LLC | 2.6% | 707,114 | 0 | 707,114 | /s/ Srinivas Akkaraju | By Srinivas Akkaraju, Managing Member | 0001888829 |
| Srinivas Akkaraju | 2.6% | 707,114 | 0 | 707,114 | /s/ Srinivas Akkaraju | Srinivas Akkaraju | 0001253170 |